Literature DB >> 2959518

Characterization of metallothionein-like protein in rat brain.

M Ebadi1, S Swanson.   

Abstract

A metallothionein-like protein has been identified recently in the rat brain which resembles in some but not all aspects a hepatic metallothionein. The synthesis of this protein is stimulated following the administration of zinc and copper but not cadmium. The zinc-stimulated protein incorporates 35S cysteine 24-fold higher than the native, unstimulated protein; is blocked by actinomycin D; produces two isoforms by ion exchange chromatography on DEAE Sephadex A 25 columns; and, by high performance liquid chromatography, depicts a similar but not identical profile to zinc-stimulated hepatic metallothionein. Preliminary studies have shown that the metallothionein-like protein isoform I possesses a Mr of 6200 and consists of 60 residues with 12 cysteine and no histidine, arginine, leucine, tyrosine, or phenylalanine. Since the synthesis of this protein is reduced in the brains of zinc-deficient rats, it is postulated that the free pool of zinc may serve as one of the factors that regulates the synthesis of this protein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2959518     DOI: 10.1007/978-3-0348-6784-9_24

Source DB:  PubMed          Journal:  Experientia Suppl        ISSN: 0071-335X


  6 in total

1.  Cadmium inhibits brain calmodulin: in vitro and in vivo studies.

Authors:  P J Vig; M Bhatia; K D Gill; R Nath
Journal:  Bull Environ Contam Toxicol       Date:  1989-10       Impact factor: 2.151

2.  The amino acid composition of the zinc-induced metallothionein isoforms in rat brain.

Authors:  M Ebadi; D Babin
Journal:  Neurochem Res       Date:  1989-01       Impact factor: 3.996

3.  Experimental basis for increasing the therapeutic index of cis-diamminedicarboxylatocyclobutaneplatinum(II) in brain tumor therapy by a high-zinc diet.

Authors:  F Doz; M E Berens; C F Deschepper; D V Dougherty; V Bigornia; M Barker; M L Rosenblum
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 4.  Metallothionein and anticancer agents: the role of metallothionein in cancer chemotherapy.

Authors:  F Doz; N Roosen; M L Rosenblum
Journal:  J Neurooncol       Date:  1993-08       Impact factor: 4.130

5.  Metallothionein-II inhibits lipid peroxidation and improves functional recovery after transient brain ischemia and reperfusion in rats.

Authors:  Araceli Diaz-Ruiz; Patricia Vacio-Adame; Antonio Monroy-Noyola; Marisela Méndez-Armenta; Alma Ortiz-Plata; Sergio Montes; Camilo Rios
Journal:  Oxid Med Cell Longev       Date:  2014-02-25       Impact factor: 6.543

6.  Metallothionein induction reduces caspase-3 activity and TNFalpha levels with preservation of cognitive function and intact hippocampal neurons in carmustine-treated rats.

Authors:  Gouda K Helal; Abdulaziz M Aleisa; Omayma K Helal; Salim S Al-Rejaie; Abdulaziz A Al-Yahya; Abdulhakeem A Al-Majed; Othman A Al-Shabanah
Journal:  Oxid Med Cell Longev       Date:  2009 Jan-Mar       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.